Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Analysis of the Multiple Myeloma HLA Peptidome Identifies a Naturally Presented Bcma-Derived Peptide As an Immunogenic T-Cell Epitope for Immunotherapeutic Approaches

Tatjana Bilich, Simon D. Walz, Annika Nelde, Helmut R. Salih, MD, Ana Marcu, Daniel Johannes Kowalewski, Katja Weisel, MD, Lothar Kanz, Hans-Georg Rammensee, Stefan Stevanovic, Juliane S. Walz

Blood (2018) 132 (Supplement 1): 3173.

https://doi.org/10.1182/blood-2018-99-113473

Published: 2018

Journal Articles

The HLA Ligandome Landscape of Chronic Myeloid Leukemia Delineates Novel T-Cell Epitopes for Immunotherapy

Blood (2018) 132 (Supplement 1): 4243.

https://doi.org/10.1182/blood-2018-99-113376

Published: 2018

Journal Articles

Radiofrequency Ablation of Liver Metastases from Colorectal Cancer Induces a Cancer-Specific T Cell Repertoire in Humans

Blood (2018) 132 (Supplement 1): 1120.

https://doi.org/10.1182/blood-2018-99-120381

Published: 2018

Journal Articles

Favorable Immune Signature in CLL Patients, Defined By Antigen-Specific T-Cell Responses, Might Prevent Second Skin Cancers

Annika Nelde, Daniel Johannes Kowalewski, Linus Backert, Lothar Kanz, Helmut R. Salih, MD, Hans-Georg Rammensee, Stefan Stevanovic, Juliane Sarah Walz

Blood (2017) 130 (Supplement 1): 5329.

https://doi.org/10.1182/blood.V130.Suppl_1.5329.5329

Published: 2017

Journal Articles

Definition and Characterization of a Peptide Warehouse for the Patient-Individualized Peptide Vaccination Study (iVAC-L-CLL01) after First Line Therapy of CLL

Tatjana Bilich, Annika Nelde, Daniel Johannes Kowalewski, Lothar Kanz, Hans-Georg Rammensee, Stefan Stevanovic, Helmut R. Salih, MD, Juliane Sarah Walz

Blood (2017) 130 (Supplement 1): 5346.

https://doi.org/10.1182/blood.V130.Suppl_1.5346.5346

Published: 2017

Journal Articles

Thermal Ablation of Colorectal Cancer Metastases Leads to Activation of Individual Cancer-Specific T Cell Immunity

Sebastian Haen, MD, Bianca Nussbaum, Daniel Johannes Kowalewski, Guenter Jaeger, Philippe Pereira, Stephan Clasen, Bence Sipos, Ingmar Koenigsrainer, Stefan Beckert, Silvia Wagner, Olaf H. Riess, Alfred Koenigsrainer, Stefan Stevanovic, Lothar Kanz, Hans-Georg Rammensee, Markus W. Loeffler, Cecile Gouttefangeas

Blood (2017) 130 (Supplement 1): 2282.

https://doi.org/10.1182/blood.V130.Suppl_1.2282.2282

Published: 2017

Journal Articles

Interplay Between the Immune System and Colorectal Carcinoma - Towards Tumor-Specific Peptide-Based Vaccination for Any HLA-Type

Sebastian P. Haen, MD, Daniel Johannes Kowalewski, Stefan Stevanovic, PhD, Linus Backert, Florian Dengler, Daniel Backes, Stefan Beckert, Wagner Silvia, Ingmar Koenigsrainer, Hans-Georg Kopp, MD, Oliver Kohlbacher, Alfred Koenigsrainer, MD, Lothar Kanz, MD, Hans-Georg Rammensee, PhD, Markus W. Loeffler, MD

Blood (2015) 126 (23): 1027.

https://doi.org/10.1182/blood.V126.23.1027.1027

Published: 2015

Journal Articles

Mapping the Impact of Proteasome Inhibitor Therapy on the Immunopeptidome of Multiple Myeloma: Mass Spectrometry Identifies Robust Targets for T Cell Immunotherapy

Daniel Johannes Kowalewski, Simon D. Walz, Linus Backert, Heiko Schuster, Susanne M. Rittig, MD, Katja C. Weisel, Helmut R Salih, MD, Lothar Kanz, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Juliane S Stickel, MD

Blood (2015) 126 (23): 3001.

https://doi.org/10.1182/blood.V126.23.3001.3001

Published: 2015

Journal Articles

Identification and Characterization of HLA Class I-Restricted MYD88 L265P-Derived Peptides As Tumor-Specific Targets for Immunotherapy

Annika Nelde, Juliane S Stickel, MD, Daniel Johannes Kowalewski, Oliver Olaf Wolz, Lothar Kanz, MD, Anton W. Langerak, Alice F. Muggen, Irina Bonzheim, Falko Fend, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Alexander N.R. Weber

Blood (2015) 126 (23): 2750.

https://doi.org/10.1182/blood.V126.23.2750.2750

Published: 2015

Journal Articles

Favorable Immune Signature in CLL Patients, Defined By Antigen-Specific T-Cell Responses, Might Prevent Secondary Skin Cancers

Juliane S Stickel, MD, Daniel Johannes Kowalewski, Heiko Schuster, Stefan Kahn, Linus Backert, Lothar Kanz, MD, Helmut R Salih, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD

Blood (2015) 126 (23): 1722.

https://doi.org/10.1182/blood.V126.23.1722.1722

Published: 2015

Journal Articles

The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell–based immunotherapy

Simon Walz, Juliane S. Stickel, Daniel Johannes Kowalewski, Heiko Schuster, Katja Weisel, Linus Backert, Stefan Kahn, Annika Nelde, Tatjana Stroh, Martin Handel, Oliver Kohlbacher, Lothar Kanz, Helmut Rainer Salih, Hans-Georg Rammensee, Stefan Stevanović

Blood (2015) 126 (10): 1203–1213.

https://doi.org/10.1182/blood-2015-04-640532

Published: 2015

Includes: Supplemental data

Journal Articles

HLA Ligandome Analysis of Acute Myeloid Leukemia (AML) Revealed Novel Tumor-Associated Antigens for Immunotherapy.

Juliane Sarah Stickel, MD, Claudia Berlin, Daniel Johannes Kowalewski, Heiko Schuster, Lothar Kanz, MD, Helmut R Salih, MD, Hans-Georg Rammensee, Prof., Stefan Stevanovic, PhD

Blood (2012) 120 (21): 3012.

https://doi.org/10.1182/blood.V120.21.3012.3012

Published: 2012

Journal Articles

Identification of Novel Tumor-Associated Antigens for Chronic Lymphocytic Leukemia (CLL) Based On HLA Ligandome Analysis – New Targets for Peptide Based Immunotherapy

Daniel Johannes Kowalewski, Heiko Schuster, Claudia Berlin, Lothar Kanz, MD, Helmut R Salih, MD, Hans-Georg Rammensee, Prof., Stefan Stevanovic, PhD, Juliane Sarah Stickel, MD

Blood (2012) 120 (21): 4119.

https://doi.org/10.1182/blood.V120.21.4119.4119

Published: 2012

NARROW

Analysis of the Multiple Myeloma HLA Peptidome Identifies a Naturally Presented Bcma-Derived Peptide As an Immunogenic T-Cell Epitope for Immunotherapeutic Approaches

The HLA Ligandome Landscape of Chronic Myeloid Leukemia Delineates Novel T-Cell Epitopes for Immunotherapy

Radiofrequency Ablation of Liver Metastases from Colorectal Cancer Induces a Cancer-Specific T Cell Repertoire in Humans

Favorable Immune Signature in CLL Patients, Defined By Antigen-Specific T-Cell Responses, Might Prevent Second Skin Cancers

Definition and Characterization of a Peptide Warehouse for the Patient-Individualized Peptide Vaccination Study (iVAC-L-CLL01) after First Line Therapy of CLL

Thermal Ablation of Colorectal Cancer Metastases Leads to Activation of Individual Cancer-Specific T Cell Immunity

Interplay Between the Immune System and Colorectal Carcinoma - Towards Tumor-Specific Peptide-Based Vaccination for Any HLA-Type

Mapping the Impact of Proteasome Inhibitor Therapy on the Immunopeptidome of Multiple Myeloma: Mass Spectrometry Identifies Robust Targets for T Cell Immunotherapy

Identification and Characterization of HLA Class I-Restricted MYD88 L265P-Derived Peptides As Tumor-Specific Targets for Immunotherapy

Favorable Immune Signature in CLL Patients, Defined By Antigen-Specific T-Cell Responses, Might Prevent Secondary Skin Cancers

The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell–based immunotherapy

HLA Ligandome Analysis of Acute Myeloid Leukemia (AML) Revealed Novel Tumor-Associated Antigens for Immunotherapy.

Identification of Novel Tumor-Associated Antigens for Chronic Lymphocytic Leukemia (CLL) Based On HLA Ligandome Analysis – New Targets for Peptide Based Immunotherapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only